Investor AB ser. B (INVE-B)
Stockholm Exchange · Sweden · prices in SEK · close of 22 Oct 2026
Key indicators
| Last close | SEK 409.05 |
|---|---|
| 52-week range | 306.70 – 426.80 |
| Return, 1 month / 3 months | −0.1% / +1.7% |
| Return, 1 year / 3 years | +33.1% / +115.2% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 48 |
| Volatility (1 year) | 16.8% |
| Worst drawdown (1 year) | -10.5% |
| Average daily value traded | 1,013.15M SEK |
| Dividend yield | 1.3% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Investor AB is a Swedish investment company controlled by the Wallenberg family. It builds and holds long-term stakes in established businesses across industries such as industrial equipment, telecommunications, banking and healthcare, and it also owns wholly owned subsidiaries through its Patricia Industries arm, including a medical device maker and a healthcare technology firm. Its customers are the companies it invests in and supports, and it is based in Stockholm, Sweden.
Investor AB ser. B trades under the code INVE-B on the Stockholm Exchange in Sweden, with its price quoted in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Investor AB ser. B (INVE-B) trades on the Stockholm Exchange in Sweden. It last closed at SEK 409.05 on 22 October 2026.
Its price-based Market X-Ray is 85 out of 100 (a strong price profile), ranking 11 of 912 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 33.1% and over the last three months it rose 1.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Stockholm Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 84 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 7.2% | ||
| From 52-week high | -3.5% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 1.7% | ||
| 6-month return | 8.1% | ||
| 12-month return, skipping the last month | 33.2% | ||
| Stability (higher is calmer) | 98 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 16.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -10.5% | ||
| Liquidity | 100 · Strong | Trades actively. | |
| Average daily value traded | 1,013.15M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 55 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 1.3% | ||
| Years with dividends | 6 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.0% |
|---|---|
| 1 month | −0.1% |
| 3 months | +1.7% |
| 6 months | +8.1% |
| 1 year | +33.1% |
| 3 years | +115.2% |
| 5 years | +124.9% |
Signals
| 50-day / 200-day average | 409.65 / 381.50 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 6.64 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 6 Nov 2026 | SEK 1.6000 |
| 8 May 2026 | SEK 4.0000 |
| 7 Nov 2025 | SEK 1.4500 |
| 8 May 2025 | SEK 3.7500 |
| 8 Nov 2024 | SEK 1.2000 |
| 8 May 2024 | SEK 3.6000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Stockholm Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.